好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2006 Annual Meeting | Clinical Grant Writing

Tuesday 04/04/06
06:45 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Breakfast Seminar
Karl D. Kieburtz, MD
Upon Completion:
Participants should know the basics of writing an NIH grant; the components of a clinical trial grant application; and the NIH grant review process.
No CME available
Professionalism, Systems-based Practice
Introductory
Fellow, Academician, Resident
Event Timeline
06:45 AM - 07:30 AM The NIH Clinical Trial Grant Application Process
Bernard M. Ravina, MD, MSCE
06:45 AM - 08:30 AM Breakfast
07:30 AM - 08:15 AM Basic Strategies for a Successful Grant Application
Karl D. Kieburtz, MD
08:15 AM - 08:30 AM Questions and Answers
Faculty Disclosures
Karl D. Kieburtz, MD Dr. Kieburtz has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Kieburtz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Kieburtz has stock in Clintrex Research Corp. Dr. Kieburtz has stock in Hoover Brown. An immediate family member of Dr. Kieburtz has stock in Hoover Brown. Dr. Kieburtz has stock in Safe Therapeutics. The institution of Dr. Kieburtz has received research support from NIH. The institution of Dr. Kieburtz has received research support from Michae J Fox Foundation.
Bernard M. Ravina, MD, MSCE Dr. Ravina has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Ravina has stock in Praxis.